Role of MRI in multiple sclerosis I: inflammation and lesions.
about
Imaging of multiple sclerosis: role in neurotherapeutics.Clinical-magnetic resonance imaging correlations in multiple sclerosis.The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20-Year Data from the U.S. Glatiramer Acetate Extension Study.Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosisDaclizumab treatment for multiple sclerosis.Adrenocorticotropic hormone versus methylprednisolone added to interferon β in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trialRisk factors for and management of cognitive dysfunction in multiple sclerosis.A 3T MR imaging investigation of the topography of whole spinal cord atrophy in multiple sclerosis.Update on the relationships between neuropsychological dysfunction and structural MRI in multiple sclerosis.The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis.Gender and sex hormones in multiple sclerosis pathology and therapy.The Effect of Fingolimod on Conversion of Acute Gadolinium-Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis.The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis.Tracking the Evolution of Cerebral Gadolinium-Enhancing Lesions to Persistent T1 Black Holes in Multiple Sclerosis: Validation of a Semiautomated Pipeline.Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis.Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliabilityTrimmed-likelihood estimation for focal lesions and tissue segmentation in multisequence MRI for multiple sclerosisNormal-appearing white matter permeability distinguishes poor cognitive performance in processing speed and working memory.Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.T2 lesions and rate of progression of disability in multiple sclerosis.Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.Regionally distinct white matter lesions do not contribute to regional gray matter atrophy in patients with multiple sclerosis.Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis.
P2860
Q30989935-6C2EA835-D2D6-4CF3-B5DB-36A3461F5183Q31027945-44CED319-91AF-4960-BB70-6F58294517ACQ31100010-1A127B91-11A8-42C7-A4C5-CA9CB98159B9Q33339985-909F9072-8881-46F2-B0E9-27EF81BB7002Q33382919-0EB1989D-8CA3-4FA0-957A-EA4105D561E0Q33589934-7098F2CF-39A2-4DA0-BAF2-54AE9D935283Q33893669-8E67AA6A-4BDE-4AB1-9090-8C641C0D8044Q35992874-D0F27953-E022-4E0D-BF7F-FCFB4DB8EC4EQ36419562-05D79BC8-0215-4659-BE4E-CB4A7E3554C4Q37048758-3E49F771-7251-45EE-B1BD-E3598F3AF272Q37209917-6C82EEB4-AD2F-465B-98C6-20D36220164FQ37325966-FF046133-DFDE-4060-8FC2-D2A7920C3E34Q37459099-567E424F-00C0-4BAD-86A1-292210579587Q38859250-545C684C-336B-4443-8B30-5C3F3FA6F23AQ38954336-69F6A1C6-A0CC-4300-96FE-972DE917809EQ41613266-F387543C-29D5-43B9-ABCD-0F2169483C76Q42181547-7CCEF5A9-B213-4526-8021-5B0CE350B815Q45051419-043FEB45-BDE1-418A-95DC-D7BAED9CA97AQ47242221-4073EA9A-8974-4765-A68D-83C298920A01Q48186630-3D703B2F-84EB-4E63-ABB3-C34C485912C5Q48186695-E1943D83-7E63-40E8-8B16-16463616E5ACQ48227724-8C98C3DD-6305-4B57-AFAA-E1DE080EDBEEQ48343851-DF9DCB86-8468-4644-BC96-8D8F33B8D8F5Q48415746-31B2BB4E-CBC8-4034-802A-9E88B20FB300
P2860
Role of MRI in multiple sclerosis I: inflammation and lesions.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Role of MRI in multiple sclerosis I: inflammation and lesions.
@ast
Role of MRI in multiple sclerosis I: inflammation and lesions.
@en
type
label
Role of MRI in multiple sclerosis I: inflammation and lesions.
@ast
Role of MRI in multiple sclerosis I: inflammation and lesions.
@en
prefLabel
Role of MRI in multiple sclerosis I: inflammation and lesions.
@ast
Role of MRI in multiple sclerosis I: inflammation and lesions.
@en
P356
P1476
Role of MRI in multiple sclerosis I: inflammation and lesions.
@en
P2093
Rohit Bakshi
P304
P356
10.2741/1251
P577
2004-01-01T00:00:00Z